Study of the role of hydroxychloroquine in immunological and coagulation control in patients diagnosed with Primary antiphospholipid syndrome
Not Applicable
- Conditions
- Embolism and thrombosis of unspecified veinCoagulation defect, unspecifiedI82.9D68.9
- Registration Number
- RBR-35mp4q
- Lead Sponsor
- Hemocentro- Universidade Estadual de Campinas
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Data analysis completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Confirmed diagnosis of primary antiphospholipid syndrome with thrombosis; age between 17 and 65 years old
Exclusion Criteria
Diagnosis of active neoplasia; presence of other associated autoimmune diseases; gestational period; antiphospholipid syndrome with isolated obstetric complications
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method